Hagen Brett R

Chief Accounting Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

97.7%

Avg 3M Return

+23.5%

Avg 12M Return

+61.4%

Hagen Brett R is a Chief Accounting Officer at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.

Estimated insider holdings value: $9K based on current market prices.

Holdings by Company

KLRSMar 26, 2025

Current Shares1.9K

Value$9.1K

Net Activity-116,443

Bought: 0Sold: 116.4K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 22, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	960	$0.74	$714.85	-0.6%	+2.2%	-85.3%
Jul 2, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	304	$0.72	$218.88	-0.4%	+10.0%	-84.9%
May 17, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	541	$0.75	$405.37	-0.7%	-5.8%	-80.5%
May 3, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	1,597	$0.80	$1,271.21	-2.1%	+0.3%	-68.2%
Apr 22, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	953	$0.75	$715.03	-0.6%	-0.6%	-61.5%
Apr 2, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	281	$0.77	$216.93	-0.4%	-4.9%	-54.3%
Feb 20, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	494	$0.70	$343.43	-0.6%	+9.2%	-35.7%
Feb 8, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	11,150	$0.67	$7,493.92	-12.3%	+16.2%	-35.0%
Feb 5, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	5,792	$0.67	$3,880.64	-6.0%	+20.3%	-34.7%
Jan 23, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	901	$0.67	$604.39	-0.9%	+13.9%	-40.3%